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Abstract
Background: Power analysis is a critical aspect of the design of experiments to detect an effect of a given size. When
multiple hypotheses are tested simultaneously, multiplicity adjustments to p-values should be taken into account in
power analysis. There are a limited number of studies on power analysis in multiple testing procedures. For some
methods, the theoretical analysis is difficult and extensive numerical simulations are often needed, while other
methods oversimplify the information under the alternative hypothesis. To this end, this paper aims to develop a new
statistical model for power analysis in multiple testing procedures.
Methods: We propose a step-function-based p-value model under the alternative hypothesis, which is simple
enough to perform power analysis without simulations, but not too simple to lose the information from the alternative
hypothesis. The first step is to transform distributions of different test statistics (e.g., t, chi-square or F) to distributions of
corresponding p-values. We then use a step function to approximate each of the p-value’s distributions by matching
the mean and variance. Lastly, the step-function-based p-value model can be used for theoretical power analysis.
Results: The proposed model is applied to problems in multiple testing procedures. We first show how the most
powerful critical constants can be chosen using the step-function-based p-value model. Our model is then applied to
the field of multiple testing procedures to explain the assumption of monotonicity of the critical constants. Lastly, we
apply our model to a behavioral weight loss and maintenance study to select the optimal critical constants.
Conclusions: The proposed model is easy to implement and preserves the information from the alternative
hypothesis.
Keywords: Critical constants, Multiple testing procedures, Power analysis, p-value

Background
Power analysis is a key technique in the experimental
design to reveal an effect of a given size. Traditional power
calculation usually assumes a single hypothesis test, but it
is quite common for researchers to test several hypotheses simultaneously. Clinical trials often require two or
more hypotheses to be tested, and studies which involve
comparing treatments using multiple outcome measures
happen frequently in medical research [8]. The development of high-throughput biology leads to a dramatic
increase in the number of hypothesis tests in genomics

[20]. However, there are a limited number of studies on
power analysis in multiple testing procedures. For scientific studies with multiple hypotheses, in order to correctly
control the false positives, multiplicity adjustments to
p-values should be taken into account in power analysis. A consequence of multiplicity adjustments is the
loss of power [21] and the change in sample size
requirements [16].
The p-value is a tail probability given the null hypothesis
is true. Under the null hypothesis, the p-value is a uniformly distributed random variable between 0 and 1. If the
null hypothesis is false, the p-value’s distribution depends
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on the alternative hypothesis, which usually satisfies the
inequality
Pr(P ≤ p) ≥ p,


var[ P] =

Methods
A widely used p-value model assumes that the statistic under the null hypothesis follows N(0, 12 ), and
the statistics under the alternative hypothesis follows
N(δ, 12 ). The p-values are calculated based on one-sided
test [17].
The density function of the normal-distribution-based
p-value model is


φ −1 (p) + δ

 ,
h(p) =
(2)
φ −1 (p)
with mean and variance
 +∞
(x)φ (x + δ) dx,
E[ P] =

−∞



−

(1)

i.e., the random variable P is less than a standard uniform
random variable in the stochastic order, where the random
variable P is the probability of rejecting the null hypothesis
when the alternative hypothesis is true.
In order to perform a p-value based power analysis,
certain distribution models are needed to describe the
behavior of p-values under the alternative hypothesis. In
general there are two approaches. The p-value models
based on the original test statistics [17] or based on copulas [27] are usually with complex expressions, and further
calculations or evaluations require integrations. So the
theoretical analysis is difficult and numerical simulations
are often needed. The p-value models based on Dirac
function [10, 24] are over-simplified, which limits their
application areas.
In this paper, we propose the step-function-based
p-value models under the alternative hypothesis, which
are simple enough to perform theoretical power analysis,
but not too simple to lose the information from the alternative hypothesis. Two applications in multiple testing
procedures are shown and one application in weight-loss
treatment is given.

+∞

[(x)]2 φ (x + δ) dx
+∞

−∞

2
(x)φ (x + δ) dx

.

Alternatively, we propose a step-function-based p-value
model under the alternative hypothesis, which has a density function
⎧
1−g
⎪
⎪
⎨f, 0 ≤ p ≤ f −g,
h(p) =
(3)
1−g
⎪
⎪
⎩ g,
< p ≤ 1,
f −g
with mean and variance
E[ P] =

1 − 2g + fg

 ,
2 f −g

var[ P] =

1 + 4fg 2 + 4f 2 g − 3f 2 g 2
,

2
12 f − g

where 0 ≤ g ≤ 1 ≤ f . The parameter (f , g) indicates
the deviation of the random variable P under the stepfunction-based p-value model from a standard uniform
random variable.
For comparison between the normal-distribution-based
p-value model and the step-function-based p-value
model, the parameters (f , g) of the step-function-based
p-value model were chosen to match the means and
the variances for the normal-distribution-based p-value
model with parameter δ, as shown in Table 1. For the simplified step-function-based p-value model with parameter
f, means are matched with the normal model.
In addition, a simplified step-function-based p-value
model with a single parameter f ∈[ 1, +∞) is achieved
when assuming g = 0. The corresponding density function is
⎧
1
⎪
⎪
⎨f, 0 ≤ p ≤ f ,
h0 (p) =
(4)
1
⎪
⎪
⎩ 0,
< p ≤ 1.
f
with mean and variance
1
1
.
E[ P] = , var[ P] =
2f
12f 2
For the simplified step-function-based p-value model, a
larger parameter f corresponds to a larger effect size. As a

−∞

Table 1 Normal-distribution-based p-value model and step-function-based p-value model
Normal
δ

Mean

Step-function
SD

f

g

Simplified step-function
(1 − g)/(f − g)

f

1/f

0.2

0.444

0.286

1.249

0.795

0.451

1.127

0.888

0.5

0.362

0.274

1.728

0.555

0.380

1.382

0.724

1

0.240

0.236

2.937

0.288

0.269

2.086

0.480

2

0.079

0.130

9.061

0.059

0.105

6.357

0.157

3

0.017

0.049

37.143

0.007

0.027

29.503

0.034
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special case, when f = 1, the distribution is uniform [ 0, 1].
The probability density functions and the cumulative distribution functions of the normal-distribution-based and
the step-function-based p-value models are compared in
Fig. 1. The step-function-based p-value models serve an
approximation to the p-value models based on the original
test statistics.
Based on the univariate model, the corresponding multivariate p-value model has a density function
n

(5)

where different hi (·)’s may have different parameters fi ’s
and gi ’s. In the following sections, the simplified stepfunction-based p-value model is applied to two problems
in multiple testing procedures.

where c1 ≥ c2 . This equality is equivalent to

Results

(1 − 2c2 ) + c1 (2c2 − c1 ) α = 0.

Application: optimal choices of the critical constants
n

1 −c2 )α
, which is less than zero. So c2
− (c1−c
1α

Rejection probability
⎧ 

2
⎪
⎨ c2 f1 + f2 α + c1 (c1 − 2c2 ) f1 f2 α ,
2
=
c1 f1 + c2 f2 α − c1 c2 f1 f2 α ,
⎪
⎩
1,

0.4

0.6

0.8

1
c1 α ,
1
1
c1 α ≤ f2 ≤ c2 α ,
1
1
c1 α orf2 ≥ c2 α .

when f1 ≤ f2 ≤
when f1 ≤
when f1 ≥

Step-function
Simplified step-function
Normal

0.0
0.2

=

When the global hypothesis contains two single
hypotheses (n = 2), there are two configurations of

cumulative distribution function

2.0
1.5
1.0
0.0
0.0

dc2
dc1

decreases when c1
increases.
By using the simplified step-function-based p-value
model, without loss of generality, we assume 1 ≤ f1 ≤ f2 ,
the probability of rejecting the global hypothesis is

Step-function
Simplified step-function
Normal

0.5

probability density function

and the derivative

1.0

2.5

The global test compares p(n−i+1) with its corresponding critical constant ci α for every i = 1, · · · , n. If for
some i’s, p(n−i+1) ≤ ci α, then the global null hypothesis is rejected. Simes [25] proposed a test with ci =
(n − i + 1) /n, and other choices of ci ’s were proposed by
Rom [22], Cai and Sarkar [7], Gou and Tamhane [11].

1−c21 α
2(1−c1 α) ,

0.8



Pr ∪ni=1 p(n−i+1) ≤ ci α ≤ α.

From (6) we get c2 =

0.6

Assume n hypotheses {Hi }ni=1 with p-values pi i=1 . Sort
p-values as p(1) ≤ · · · ≤ p(n) , and H(1) , · · · , H(n) are
the corresponding null hypotheses. Consider testing the
global null hypothesis ∩ni=1 Hi under the control of type I
error [15]

(6)

0.4

hi (pi ) ,
i=1

0.2

h(p1 , · · · , pn ) =

Among different choices of critical constants ci ’s, people usually run simulations [19] or rely on numerical
calculations [14] to make power comparison in order
to choose suitable sets of critical constants. Besides the
existing computationally intensive methods, the stepfunction-based p-value model is an alternative choice to
theoretically calculate the powers and make comparisons
between different multiple testing procedures.
In this section we first show how the most powerful critical constants can be chosen using our proposed method
for a global test with two hypotheses, and then we can
apply the successive recursion process to calculate the
power for a global test with n hypotheses. For a global
test with two single hypotheses, the control of type I error
under independence requires


Pr p(2) ≤ c1 α ∪ p(1) ≤ c2 α = α,

1.0

p

Fig. 1 Normal-distribution-based and step-function-based p-value models (δ = 0.5)

0.0

0.2

0.4

0.6
p

0.8

1.0
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true and non-true null hypotheses where the global null
hypothesis is false: (1) one true null hypothesis (n0 = 1)
and one false null hypothesis (m = 1), and (2) two false
null hypotheses (m = 2).
First, assume that one null hypothesis is true and the
other is false, say, f1 = 1 and f2 = f , then the power is
⎧ 

2
⎪
⎨ c2 1 + f  α + fc1 (c1 − 2c2 ) α
2
Power =
c1 + fc2 α − fc1 c2 α ,
⎪
⎩
1,

when f ≤ c11α ,
when c11α ≤ f ≤
when f ≥ c21α .

1
c2 α ,

When f ≤ c11α , from (6) it follows that c1 (c1 − 2c2 ) α =
1 − 2c2 , therefore


 


c2 1 + f α + fc1 (c1 − 2c2 ) α 2 = f − f − 1 c2 α,
hence power increases when c2 decreases (c1 increases).
When c11α ≤ f ≤ c21α , from (6) we get c1 c2 α =


1
2
2 2c2 − 1 + c1 α , consequently



α
f + 2c1 − f αc21
c1 + fc2 α − fc1 c2 α 2 =
2

2 
1 
.
1 + f 2 α − f αc1 − 1
=
2f
Note that f αc1 ≥ 1, so power increases when c1
decreases (c2 increases).
We calculate the maximal power for different f ’s.
When we assume the alternative hypothesis has a small
√
effect size, where f ≤ 1/ α, the maximal power is
√
achieved when c2 = 0 and c1 = 1/ α. When we
assume the alternative hypothesis
has a moderate
effect


√
√
size, where 1/ α < f ≤ 1 + 1 − α /α,
the
max
imal
power
is
achieved
when
c
=
1/
f
α
and
c
1
2 =
 2
 


f α − 1 / 2αf f − 1 , so when f increases, we can follow the strategy to decrease c1 (increase c2 ) to achieve the
maximal power. When we assume the
 alternative
hypoth√
esis has a large effect size, where f > 1 + 1 − α /α, the
maximal power
 is achieved when we choose a test with
c2 ≥ 1/ f α , so when f is large enough, different tests
have similar power.
⎧
⎪
when f ≤ √1α ,
⎪ f α,
⎨
√
2
max Power = 1+f2f α , when √1α < f ≤ 1+ α1−α ,
⎪
√
⎪
⎩
1,
when f > 1+ α1−α .
(7)
Second, assume that both null hypothesis are false with
the same effect size, say, f1 = f2 = f , then the power is


Power =

2fc2 α + f 2 c1 (c1 − 2c2 ) α 2 ,
1,

When f ≤
then

when f ≤
when f ≥

1
c1 α , from (6) we get c1 (c1

1
c1 α ,
1
c1 α .

− 2c2 ) α = 1−2c2 ,



 
2fc2 α + f 2 c1 (c1 − 2c2 ) α 2 = f α f − 2 f − 1 c2 ,

power increases when c2 decreases (c1 increases).
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We calculate the maximal power for different f values.
When we assume both hypotheses are false and with a
√
small effect size, where f ≤ 1/ α, the maximal power is
√
achieved when c2 = 0 and c1 = 1/ α. When we assume
both false hypotheses have a big effect size, where f ≥
√
1/ α, the maximal
the test satis  power is achieved when
√
√
fies c1 ≥ 1/ f α . By taking both f ≤ 1/ α and f ≥ 1/ α
√
into account, it follows that c1 = 1/ α and c2 = 0 is the
uniformly best choice when both null hypotheses are false.
 2
f α, when f ≤ √1α ,
(8)
max Power =
1,
when f > √1α .
In general, for a global test with n single hypotheses, where m of them are true significances (false null
hypotheses), define the probabilities as
Bn,m,i
⎧


⎪
⎪ Prn,m p(n) ≤ c1 α ,
⎨


= Prn,m p(n) > c1 α, · · · , p(n−i+2) > ci−1 α, p(n−i+1) ≤ ci α ,
⎪
⎪


⎩
Prn,m p(n) > c1 α, · · · , p(1) > cn α ,

i = 1,
i = 2, · · · , n,
i = n + 1,

where Prn,m indicates the probability for n hypotheses,
where m is the number of the true significances, and n0 =
n − m is the number of the true nulls.
Since


Bn,m,n = Prn,m p(n) > c1 α, · · · , p(2) > cn−1 α, p(1) ≤ cn α

= (n − m) Prn−1,m p(n−1) > c1 α, · · · , p(1)
> cn−1 α) Pr1,0 (p ≤ cn α)

+ mPrn−1,m−1 p(n−1) > c1 α, · · · , p(1)
> cn−1 α) Pr1,1 (p ≤ cn α) ,
we have the recurrence relation for i = n


Bn,m,n = (n−m)cn αBn−1,m,n +m fcn α ∧ 1 Bn−1,m−1,n .
(9)
Similarly, for general i, since

Bn,m,i = Prn,m p(n) > c1 α, · · · , p(n−i+2)

> ci−1 α, p(n−i+1) ≤ ci α

n−m
= n−i+1
Prn−1,m p(n−1) > c1 α, · · · , p(n−i+1)

> ci−1 α, p(n−i) ≤ ci α Pr1,0 (p ≤ ci α)

m
Prn−1,m−1 p(n−1) > c1 α, · · ·, p(n−i+1)
+ n−i+1

> ci−1 α, p(n−i) ≤ ci α Pr1,1 (p ≤ ci α) ,
we have the general recurrence relation for i
n−m
ci αBn−1,m,i
n−i+1
(10)


m
+
fci α ∧ 1 Bn−1,m−1,i .
n−i+1
Finner and Roters [9], Cai and Sarkar [7], and Gou and
Tamhane [11] defined a special case of the probability
Bn,m,i for m = 0 to calculate the type I error under the
Bn,m,i =

Zhang and Gou BMC Medical Research Methodology (2016) 16:135

global null hypothesis. They proved a recurrence relationship among Bn,0,i ’s. We generalize this result to Bn,m,i ’s and
have this recurrence relationship (10) under the simplified
step-function-based p-value model for power analysis.
By starting from
B1,0,1 = c1 α,

B1,0,2 = 1 − c1 α,

B1,1,1 = fc1 α ∧ 1,

B1,0,2 = 1 − fc1 α ∧ 1,

and using the recurrence relation (10), the power is calculated by
Powern,m =

n


(11)

Bn,m,i

i=1

Note that
n+1


Bn,m,i = 1,

to have large power. Similar observations were reported
by Gou and Tamhane [11] based on simulations.
Note that in this application power is simply the probability of rejecting H0 = ∩ni=1 Hi where at least one Hi
is false. For testing multiple hypothesis, powers can be
of different types: individual, average, disjunctive, and
conjunctive, and the appropriate power concept is determined on a case-by-case basis [4]. These power definitions
can also be used in the proposed method by using the
step-function-based p-value model.
Power analysis can be complex when multiple hierarchical objectives are involved. Alosh and Huque [1] discussed
the power for testing hierarchically ordered endpoints.
The step-function-based p-value model can be applied to
various clinical trials, e.g., group sequential designs [18],
graphical procedures [5, 6].
Application: monotonicity of the critical constants

i=1

and the control of type I error is satisfied if
n
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c1 ≥ c2 ≥ · · · ≥ cn

Bn,0,i ≤ α.

i=1

When f is specified and the set of critical constants
{ci }ni=1 is given, the exact power can be calculated by using
(11). Since only arithmetic calculations are needed, the
power can be computed very fast.
For theoretical analysis, we consider the situation where
f is not too small.
Powern,m = 1,

For multiple test procedures, critical constants are often
required to satisfy [7, 12]

when f ≥

1
cn+1−m α

.

The largest possible cn+1−m is achieved by using the set
of critical constants which satisfies c1 = c2 = · · · =
cn+1−m = c, and cn−m+2 = · · · = cn = 0. The control of
type I error requires that
n−m
 n
(12)
(cα)n−i (1 − cα)i ≤ α,
i
i=0

the largest possible cn+1−m can be solved from (12). If
we only take the leading term, we have an approximate
solution
1
cn+1−m   
m n
m−1
m α
So when
 n
m ( )
m
f 
α
the maximal power
is achieved when the test satisfies

cn+1−m ≥ 1/ f α .
Note that whenm is relatively large (e.g., more than
n
n/2), the bound m m
/α is small, and the global tests
with large c1 , · · · , cn+1−m and small cn+2−m , · · · , cn tend

(13)

This requirement is called the monotonicity assumption
of critical constants.
Suppose that we have a set of critical constants
c∗1 , · · · , c∗n , and c∗k < c∗k+1 , so the monotonicity assumption
is not satisfied. Note that



Pr ∪ni=1 p(n+1−i) ≤ c∗i α = Pr ∪ni=1,i=k p(n+1−i)

≤ c∗i α ∪ p(n+1−k) ≤ c∗k+1 α
So if a test with critical constants c∗1 , · · · , c∗k−1 ,
, c∗n controls type I error below α, then another
test with critical constants c∗1 , · · · , c∗k−1 , c∗k+1 , c∗k+1 , · · · , c∗n ,
which satisfies the monotonicity assumption, also controls type I error below α, and has the same power with
the previous test which does not satisfy the monotonicity assumption. Hence, only the set of critical constants
which satisfies the monotonicity assumption needs to be
considered.
Many multiple tests have critical constants which satisfy
a strict monotonicity assumption [11, 22, 25]
c∗k , c∗k+1 , · · ·

c 1 > c2 > · · · > c n .

(14)

Some multiple tests satisfy the monotonicity assumption (13), but do not satisfy the strict monotonicity
assumption (14) [3, 26]. In general, these tests are not as
powerful as the tests which satisfy the strict monotonicity assumption (14) [11]. Our step-function-based p-value
models can explain that this assumption is necessary
because the corresponding tests are generally more powerful than other tests which do not satisfy this assumption.
For multiple tests with two single hypotheses, by using
the simplified step-function-based p-value model, we
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have several observations: (1) when there is one true null
and
hypothesis
 one false null hypothesis, only if f =
√
1 + 1 − α /α, the test which does not satisfy (14) can
be more powerful than or as powerful as all the tests which
satisfy (14), (2) when there are two false null hypotheses, the test does not satisfy (14) is less powerful than
some of the tests which satisfy (14) for all f values. In
general, on the parameter space of the effect size (under
simplified step-function-based p-value model, the effect
size is a function of parameter f ), the tests which do not
satisfy (14) have more power than all other tests which
satisfy (14) only at a zero measure subspace of the effect
size. This fact explains that usually people prefer multiple
tests which satisfy the strict monotonicity property (14),
because these tests are generally more powerful than the
tests which do not satisfy (14).
A worked example

Annesi et al. [2] evaluated behavioral weight-loss treatments. They recruited 110 women whose BMI’s are
between 30 and 40 kg/m2 , and randomly assigned the participants to a comparison treatment with a print manual
and telephone follow-ups, or an experimental treatment
of the coach approach exercise-support protocol. The selfefficacy for controlled eating (SE-eating) is one of the
psychological predictors of behavioral changes. Annesi et
al. [2] reported that during the weight-loss phase (month
0-6), the SE-eating increases in the experimental group
were significantly greater than the increases in the comparison group with t = 2.88, and there was no significant
between-group difference during the weight-loss maintenance phase (month 6-24) with t = −0.48.
The increases of the self-efficacy for controlled eating were evaluated both during the weight-loss phase
and during the weight-loss maintenance phase, so the
multiplicity adjustment is advised to apply. To choose
the optimal multiplicity correction based on the estimated effect size from the pilot study, we recommend
our proposed step-function-based p-value model because
it is easy to implement and preserves the information
from the alternative hypothesis. If we take the weightloss study by Annesi et al. [2] as a pilot study, we
have the information that the standardized SE-eating
increase during the weight-loss phase is normally distributed with mean δ = 2.88 and variance 1, and the
increase during the weight-loss maintenance phase is normally distributed with mean δ = 0 and variance 1.
To match the mean for the normal-distribution-based
p-value model with parameter δ = 2.88, the parameter f of the simplified step-function-based p-value model
is 23.979. From (7) and by using the significance level
α = 0.05, the maximal power is (1 + f 2 α)/(2f ) = 62 %,
and
choice
 the optimal

  ofcritical
constants is (c1 , c2 ) =
1/ f α , f 2 α − 1 / 2αf f − 1
= (0.8341, 0.5036).
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So the larger p-value is compared with 0.8341α and the
smaller p-value is compared with 0.5036α, and if any pvalue is less than the corresponding critical value, the
global null hypothesis will be rejected.
The step-function-based p-value models for power
analysis simplify the theoretical analysis that is difficult
in many situations. At the same time, information of loss
remains at an acceptable level. Finner and Gontscharuk
[10] and Sarkar et al. [24] used a tool called the Dirac–
uniform configuration for power analysis, where all pvalues under the false null hypotheses follow a Dirac distribution with point mass at 0. When the Dirac-uniform
configuration is applied to Annesi et al.’s [2] study, the
information of δ is lost, and any choice of positive critical
constants (c1 , c2 ) will result a claim of significance. Under
the p-value model based on Dirac function, all choices of
critical constants have the same power, and the optimal
choice is unable to be located.
The Dirac-uniform configuration is too brief to include
necessary information to choose the optimal critical constants. Hung et al. [17] discussed a p-value model based on
normal distribution. By using Annesi et al.’s [2] research as
a pilot study, one test statistic is N(δ, 12 ), and the other test
statistic is N(0, 12 ). The probability of rejecting the global
null hypothesis is
 −1
 −1 (c2 α)  +∞
 (c1 α)  −1 (c1 α)
Power =
+
−∞


+

+∞



−∞

−1 (c2 α)



−∞

−1 (c1 α)

−1 (c1 α) −∞

φ(x1 + δ)φ(x2 ) dx1 dx2


= c1 α ·  −1 (c1 α) + δ



+ c2 α 1 −  −1 (c1 α) + δ


+ (1 − c1 α)  −1 (c2 α) + δ ,
The optimal choice of critical constants is followed by
solving
maximizec1 ,c2
subject to

Power (c1 , c2 )

(15)

(1 − 2c2 ) + c1 (2c2 − c1 ) α = 0.

This optimization problem has no explicit solution.
When δ = 2.88 and α = 0.05, the optimal solution
is (c1 , c2 ) = (1.0076, 0.4998). While the step-function
based p-value model and the normal-distribution based
p-value model produce similar choices of critical constants (c1 , c2 ), the model based on step function has an
explicit solution of critical constants and requires little
computational effort.

Discussion and conclusions
We have given a step-function-based p-value model and
its simplified version. These p-value models are simple
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and concise to perform theoretical power analysis. In
addition, different test statistics, for example, t, chi-square
or F, can be transformed to the p-value scale. These
models can be applied to the field of multiple testing procedures to explain the assumption of monotonicity of the
critical constants. We also use these p-value models to
choose suitable sets of critical constants with more power.
In this paper, we consider the independent p-values for the
multivariate cases. Dependence structures can be brought
into these p-value models, like Sarkar et al. [23] or Gou
and Tamhane [13], and we will report the dependent multivariate p-value models in a separate paper. Finally, there
are many applications of the step-function-based p-value
models, and multiple testing procedure is an example in
point.
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